Ignite Creation Date:
2024-05-06 @ 2:54 AM
Last Modification Date:
2024-10-26 @ 11:25 AM
Study NCT ID:
NCT02151123
Status:
UNKNOWN
Last Update Posted:
2018-08-15
First Post:
2014-05-27
Brief Title:
Metabiomics Colon Cancer Clinical Research Study
Sponsor:
Metabiomics Corp
Organization:
Metabiomics Corp
Study Overview
Official Title:
Metabiomics Colon Cancer Clinical Research Study
Status:
UNKNOWN
Status Verified Date:
2018-08
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The specific aim of the study is to determine the false negative rate of the Metabiomics Colon Polyp and Colorectal Cancer Assay for Cancer
Detailed Description:
The purpose of this study is to conduct clinical research to investigate the association of the gut microbiome with colonic neoplasia In this case several types of gut microbiome samples will be collected from patients undergoing colectomy for colonic adenocarcinoma those samples will be tested by Metabiomics Colon Polyp and Colorectal Cancer Assay and the percentage of false negative test returns a negative for cancer results determined
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None